Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Advances in Development, Characterisation and Application of Nasal Drug Delivery Systems"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 23705
Special Issue Editor
Interests: nasal drug delivery; nasal powders; spray-drying; nanoparticles; in situ gelling systems; nasal deposition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Nasal route of administration receives significant scientists’ attention in local and systemic drug delivery, brain targeting and mucosal vaccination. Innovative nasal drug delivery systems are being designed to increase drug availability at the site of action, reduce possible side-effects and improve patient compliance, leading to improved therapy outcome. The anatomy and physiology of the nasal cavity and/or nasal mucosa are recognised as the most critical factors in nasal drug delivery. This indicates the need for advancing and implementation of in vitro/ex vivo characterisation methods enabling the prediction of performance/therapeutic potential of nasal delivery system, and efficiency of delivery to the targeted region of the nasal cavity.
The scope of this special issue is to highlight the latest strategies and approaches in development, characterisation and application of nasal drug delivery systems. Authors are invited to submit their original research or review articles within this subject area.
Prof. Dr. Anita Hafner
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nasal drug delivery
- nasal powders
- in situ gelling systems
- cell models
- nasal deposition
- nasal delivery device